Ubs Group Ag Gbs Inc. Transaction History

Ubs Group Ag

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 08, 2023	BUY	$0.0 - $0.47 $0 - $4,698	9,997 Added 1317.13%	10,756 $0
Q3 2022 Nov 10, 2022	SELL	$0.39 - $0.79 $4,642 - $9,404	-11,905 Reduced 94.01%	759 $0
Q2 2022 Aug 10, 2022	BUY	$0.56 - $1.31 $819 - $1,917	1,464 Added 13.07%	12,664 $8,000
Q1 2022 May 16, 2022	BUY	$0.43 - $1.7 $896 - $3,544	2,085 Added 22.87%	11,200 $9,000
Q4 2021 Feb 14, 2022	BUY	$1.26 - $2.45 $3,506 - $6,818	2,783 Added 43.95%	9,115 $13,000
Q3 2021 Nov 15, 2021	BUY	$2.26 - $4.29 $14,310 - $27,164	6,332 New	6,332 $16,000
Q2 2021 Aug 13, 2021	SELL	$2.65 - $5.72 $4,070 - $8,785	-1,536 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$5.21 - $8.25 $2,526 - $4,001	485 Added 46.15%	1,536 $9,000
Q4 2020 Feb 11, 2021	BUY	$7.4 - $11.02 $7,777 - $11,582	1,051 New	1,051 $8,000

Ticker GBS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 14,889,900
Description
GBS Inc. operates as a biosensor diagnostic technology company. It offers Saliva Glucose Biosensor that uses saliva to measure glucose non-invasively. The company also focuses on developing COV2 test, a biosensor test can be used as a complement to the (RNA) virus detection test; and a biosensor platform comprising of biochemistry, immunology, t...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.